Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leveraging Kinase Drugs for Neurosciences: Discovery of Selective, CNS-Penetrant Reversible Bruton's Tyrosine Kinase Inhibitors as Therapeutics for Neuroinflammation.

Journal of medicinal chemistry·2026
Same author

Correction to "ROSHAMBO2: Accelerating Molecular Alignment for Large Chemical Libraries with GPU Optimization and Algorithmic Advances".

Journal of chemical information and modeling·2026
Same author

ROSHAMBO2: Accelerating Molecular Alignment for Large Chemical Libraries with GPU Optimization and Algorithmic Advances.

Journal of chemical information and modeling·2025
Same author

Macrocyclic Rearrangement Ion Fragmentation of Glutathione Conjugates of Cyclobutane-Containing Covalent BTK Inhibitors.

Journal of the American Society for Mass Spectrometry·2025
Same author

Health Care Utilization in an Academic Integrative Medicine Center, 2011-2022.

Journal of integrative and complementary medicine·2025
Same author

Broadly neutralizing antibodies targeting pandemic GII.4 variants or seven GII genotypes of human norovirus.

Science translational medicine·2025

Related Experiment Video

Updated: Mar 21, 2026

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.7K

Application of protein language models for antibody developability prediction.

Samad Amini1, Yimin Huang1, Mark Julian1

  • 1Research, Biogen, Cambridge, MA, USA.

Mabs
|March 20, 2026
PubMed
Summary

Protein language models (PLMs) enhance antibody discovery by improving developability assessments. Fine-tuning PLMs on antibody sequence data boosts predictive performance for critical developability assays.

Keywords:
Developabilitymachine learningprotein language models

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K
A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

70.1K

Related Experiment Videos

Last Updated: Mar 21, 2026

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

2.7K
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

1.3K
A Protocol for Computer-Based Protein Structure and Function Prediction
16:41

A Protocol for Computer-Based Protein Structure and Function Prediction

Published on: November 3, 2011

70.1K

Area of Science:

  • Biotechnology
  • Computational Biology
  • Immunology

Background:

  • Protein language models (PLMs) show promise for predicting antibody sequence-property relationships.
  • Their real-world utility in industrial antibody discovery pipelines needs further investigation.

Purpose of the Study:

  • To systematically evaluate state-of-the-art PLMs for antibody developability assessment.
  • To determine the effectiveness of domain-adaptive fine-tuning and sequence likelihoods for predicting developability risks.

Main Methods:

  • Evaluated multiple PLMs using internal datasets of antibody sequences and developability assay measurements from 33 therapeutic programs.
  • Assessed developability across three dimensions: polyspecificity reagent (PSR), hydrophobic interaction chromatography (HIC), and AC-SINS.
  • Compared performance of fine-tuned PLMs against pretrained representations and analyzed sequence likelihoods as unsupervised indicators.

Main Results:

  • Domain-adaptive fine-tuning consistently improved PLM predictive performance across all evaluated developability assays.
  • Sequence likelihoods from pretrained PLMs served as useful, albeit varied, unsupervised indicators of developability risk.
  • PLMs demonstrated robust and complementary signals for antibody developability assessment.

Conclusions:

  • PLMs, particularly when fine-tuned, offer significant improvements in predicting antibody developability.
  • These models support practical applications in early-stage antibody candidate optimization and selection.
  • PLMs are valuable tools for enhancing the efficiency and success rate of therapeutic antibody discovery.